Hyperkalemia associated with inhibitors of the renin-angiotensin- aldosterone system: Balancing risk and benefit

Circulation

Volumn 118, Issue 16, 2008, Pages 1609-1611

  Desai, Akshay ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aldosterone; Drugs; Editorials; Heart failure; Myocardial infarction; Potassium

Indexed keywords

ALDOSTERONE RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; HEPARIN; LOOP DIURETIC AGENT; PENTAMIDINE; POTASSIUM; SPIRONOLACTONE; TRIMETHOPRIM; ALDOSTERONE ANTAGONIST; DRUG DERIVATIVE;

ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; DIETARY INTAKE; DISEASE ASSOCIATION; DOSE RESPONSE; EDITORIAL; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HYPERKALEMIA; KIDNEY DISEASE; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SODIUM TRANSPORT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HEART DISEASE; HUMAN; NOTE; RISK FACTOR;

ALDOSTERONE ANTAGONISTS; HEART DISEASES; HUMANS; HYPERKALEMIA; RENIN-ANGIOTENSIN SYSTEM; RISK ASSESSMENT; RISK FACTORS; SPIRONOLACTONE;

EID: 55949115945     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.807917     Document Type: Editorial

References (10)

1. Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351:585-592.
2. Schoolwerth AC, Sica DA, Ballermann BJ, Wilcox CS; Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Renal considerations in angiotensin-converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation. 2001;104:1985-1991.
3. Desai AS, Swedberg K, McMurray JJV, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA; on behalf of the CHARM Program Investigators. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM program. J Am Coll Cardiol. 2007;50:1959-1966.
4. Pitt B, Bakris G, Ruilope LM, DiCarlo L, Mukherjee R; on behalf of the EPHESUS Investigators. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation. 2008;118:1643-1650.
5. McMurray JJV, O'Meara E. Treatment of heart failure with spironolactone: trial and tribulations. N Engl J Med. 2004;351:526-528.
6. Shah KB, Rao K, Sawyer R. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure. J Am Coll Cordial. 2005;46:845-849.
7. Bozkurt B, Agoston I, Knowlton AA. Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines. J Am Coll Cardiol. 2003;41:211-214.
8. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J, for The Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717.
9. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 2004;351:543-551.
10. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110:588-636.